Lobbyists and executives from top pharma companies went to the White House on Thursday to argue against the Senate drug-price bill. Representatives from some drugmakers, including Amgen and Pfizer, met with President Donald Trump about the bill, which the White House has publicly supported. (Reuters)

Meanwhile, Senate Finance Committee leaders want to revive the proposal to eliminate rebates. Committee Chairman Chuck Grassley (R-IA) said he wants to include the proposal in the final drug-price bill, which was introduced on Tuesday. The proposal was pulled by the White House this month. (CNBC)

Facebook and Instagram will restrict alcohol, tobacco and e-cigarette content. The new policy will prohibit all private sales, trades, transfers and gifts of alcohol and tobacco products on the platforms. However, influencers will be allowed to promote these products and will not have to age-restrict posts. (CNN)

In the second day of hearings, Juul executives defended themselves in front of Congress. Company cofounder James Monsees said the company developed its products to help adult smokers who want to quit, but he acknowledged “a significant number” of teens use Juul products. (Associated Press)

Vertex CEO Jeffrey Leiden is set to step down next year. Reshma Kewalramani, Vertex’s chief medical officer, will take over as president and CEO on April 1. She will be the first woman to run a large biotech company. (STAT)